azides has been researched along with n-bromoacetyl-4-azido-l-phenylalanine methyl ester in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 5 (83.33) | 2.80 |
| Authors | Studies |
|---|---|
| de Groot, N; Feigenbaum, AM; Hochberg, AA; Klausner, YS | 1 |
| Fox, GF | 1 |
| Mactier, H | 1 |
| Crowley, N; Fox, GF | 1 |
| El-Dib, M; El-Shibiny, H; Inder, TE; Munster, C; Walsh, BH; Yang, E | 1 |
| Arasu, A; Arattu Thodika, FMS; Chapman-Hatchett, N; Chittenden, N; Dassios, T; Greenough, A; Harris, C; Johnson, K; Williams, EE | 1 |
3 review(s) available for azides and n-bromoacetyl-4-azido-l-phenylalanine methyl ester
| Article | Year |
|---|---|
Controversies and discussion of the BAPM Framework for the perinatal management of extreme preterm birth before 27 weeks of gestation.
Topics: Azides; Female; Humans; Infant, Newborn; Infant, Premature; Perinatal Care; Pregnancy; Premature Birth | 2021 |
Perspective from the chair of the BAPM Working Group on perinatal management of extreme preterm birth before 27 weeks of gestation.
Topics: Azides; Female; Humans; Infant, Newborn; Infant, Premature; Intensive Care Units, Neonatal; Perinatal Care; Pregnancy; Premature Birth | 2021 |
Review of the new BAPM framework for practice (2019): Perinatal management of extreme preterm birth before 27 weeks of gestation.
Topics: Azides; Female; Humans; Infant, Newborn; Infant, Premature; Pregnancy; Premature Birth | 2021 |
3 other study(ies) available for azides and n-bromoacetyl-4-azido-l-phenylalanine methyl ester
| Article | Year |
|---|---|
N-bromoacetyl-p-azido-L-phenylalanine methyl ester: a bifunctional chemically and photo-activated cross-linking reagent.
Topics: Azides; Endoplasmic Reticulum; Glutathione; Humans; Indicators and Reagents; Phenylalanine; Photochemistry | 1978 |
Differences in standardized neonatal encephalopathy exam criteria may impact therapeutic hypothermia eligibility.
Topics: Asphyxia Neonatorum; Azides; Humans; Hypothermia, Induced; Hypoxia-Ischemia, Brain; Infant; Infant, Newborn; Infant, Newborn, Diseases | 2022 |
Risk assessment of survival and morbidity of infants born at <24 completed weeks of gestation.
Topics: Azides; Female; Humans; Infant; Infant, Newborn; Morbidity; Pregnancy; Retrospective Studies; Risk Assessment | 2023 |